Michael Elliott
Chief Tech/Sci/R&D Officer chez IMMUNOVANT, INC.
Provenance du réseau au premier degré de Michael Elliott
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 25 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Michael Elliott via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| IMMUNOMEDICS, INC. | Biotechnology | Investor Relations Contact Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal | |
| ATHENAHEALTH, INC | Packaged Software | Corporate Officer/Principal | |
| CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
NeoTract, Inc.
 NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| ANAPTYSBIO, INC. | Biotechnology | Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Chairman Director/Board Member | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
| ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Long Island University | College/University | Undergraduate Degree | |
| Marquette University | College/University | Undergraduate Degree | |
| St. Louis College of Pharmacy | College/University | Doctorate Degree | |
| University of Iowa | College/University | Graduate Degree | |
AM-Pharma Holding BV
 AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
| State University of New York at Binghamton | College/University | Undergraduate Degree | |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Point32health Services, Inc.
 Point32health Services, Inc. Life/Health InsuranceFinance Tufts Associated Health Plans, Inc. provides healthcare plans. It offers health care coverage options to individuals and employer groups. The firm also offers choice tiered network option plan and Steward Community Choice, a community-based plan, developed in conjunction with Steward Health Care System. The company was founded by Morton A. Madoff in 1979 and is headquartered in Watertown, MA. | Life/Health Insurance | Director/Board Member | |
Immunetrics, Inc.
 Immunetrics, Inc. BiotechnologyHealth Technology Immunetrics, Inc. operates as a bio-simulation company. The company was founded by Carson Chow, Timothy R. Billiar, Gilles Clermont, Mitchell P. Fink and Yoram Vodovotz in 2001 and is headquartered in Pittsburgh, PA. | Biotechnology | Director/Board Member | |
| CELLDEX THERAPEUTICS, INC. | Medical/Nursing Services | Director/Board Member | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member | |
| Columbia University Medical Center | College/University | Corporate Officer/Principal | |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| The University of Nebraska-Lincoln | College/University | Doctorate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Yale School of Medicine | College/University | Doctorate Degree | |
| The Indiana University School of Medicine | College/University | Corporate Officer/Principal | |
| MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | General Counsel | |
| Washington University School of Law | College/University | Graduate Degree | |
| Stony Brook University School of Medicine | College/University | Doctorate Degree | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Operating Officer | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| EARGO, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| PROVENTION BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal President Director of Finance/CFO | |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The private company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Pharmaceuticals: Major | Chairman | |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member | |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The private company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member | |
Flexion, Inc.
 Flexion, Inc. Information Technology ServicesTechnology Services Flexion, Inc. is an American company that offers services to help businesses with digital transformation, innovative development, and modernization. The private company provides IT staffing and work to improve the efficiency, security, and user experience of their clients' systems. Flexion uses a rigorous agile practice to build flexible solutions that enable their clients' businesses to grow. | Information Technology Services | General Counsel | |
| Roivant Social Ventures, Inc. | Director/Board Member | ||
| Focus Biomedical Consulting LLC | Chief Executive Officer | ||
| New York University School of Medicine | College/University | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 45 |
| Pays-Bas | 3 |
| Belgique | 2 |
| Suisse | 2 |
| Canada | 2 |
Sectorielle
| Health Technology | 30 |
| Consumer Services | 14 |
| Technology Services | 3 |
| Health Services | 3 |
| Commercial Services | 2 |
Opérationnelle
| Director/Board Member | 72 |
| Corporate Officer/Principal | 40 |
| Director of Finance/CFO | 19 |
| Independent Dir/Board Member | 18 |
| Undergraduate Degree | 18 |
Relations les plus connectées
| Insiders | |
|---|---|
| Frank Torti | 35 |
| Atul Pande | 20 |
| George Migausky | 18 |
| Andrew Fromkin | 16 |
| Douglas Hughes | 15 |
| Rita Jain | 14 |
| W. Middlekauff | 14 |
| Eric Venker | 12 |
| Peter Salzmann | 10 |
| Pamela Connealy | 10 |
| Mark Levine | 8 |
| William L. Macias | 7 |
| John Strumbos | 7 |
| Jay Stout | 5 |
| Ian Gourley | 5 |
- Bourse
- Insiders
- Michael Elliott
- Connexions Sociétés
